Clinical Trials

NCT05271240 | RECRUITING | PHASE3
432 participants

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2022-04-27
Completion:
2027-04-01
Conditions
  • Glioblastoma
  • Glioblastoma Multiforme
  • Glioma, Malignant
  • GBM
  • Brain Cancer
  • Glioblastoma, IDH-wildtype
  • Glioblastoma Multiforme, Adult
Interventions
  • DRUG
No Results Yet
NCT05231122 | RECRUITING | PHASE2
80 participants

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2024-03-12
Completion:
2027-03-15
Conditions
  • Ovarian Clear Cell Adenocarcinoma
  • Platinum-Sensitive Ovarian Carcinoma
  • Recurrent Endometrial Serous Adenocarcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Fallopian Tube Serous Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Primary Peritoneal Clear Cell Adenocarcinoma
  • Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Primary Peritoneal Serous Adenocarcinoma
Interventions
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT05209438 | RECRUITING | NA
20 participants

Cereset Research for Caregivers

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2022-06-16
Completion:
2027-07-31
Conditions
  • Caregivers
Interventions
  • DEVICE
No Results Yet
NCT05085704 | RECRUITING
20 participants

Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

Study Type:
OBSERVATIONAL
Last Updated:
2026-06-01
Start Date:
2022-05-03
Completion:
2029-06-01
Conditions
  • Glut1 Deficiency Syndrome 1
  • Glucose Metabolism Disorders
  • Epilepsy
  • Glut1 Deficiency Syndrome 1, Autosomal Recessive
  • Glucose Transporter Type 1 Deficiency Syndrome
  • Glucose Transporter Protein Type 1 Deficiency Syndrome
  • Glucose Transport Defect
Interventions
  • DEVICE
No Results Yet
NCT05039801 | RECRUITING | PHASE1
54 participants

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-01
Start Date:
2021-09-30
Completion:
2028-03-30
Conditions
  • Stage IIIA Uterine Corpus Cancer AJCC v8
  • Advanced Endometrial Carcinoma
  • Advanced Head and Neck Squamous Cell Carcinoma
  • Advanced Malignant Solid Neoplasm
  • Advanced Melanoma
  • Advanced Ovarian Clear Cell Adenocarcinoma
  • Chondrosarcoma
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Pathologic Stage III Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Pathologic Stage IV Cutaneous Melanoma AJCC v8
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Refractory Endometrial Carcinoma
  • Refractory Head and Neck Squamous Cell Carcinoma
  • Refractory Melanoma
  • Refractory Ovarian Clear Cell Adenocarcinoma
  • Refractory Ovarian High Grade Serous Adenocarcinoma
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Uterine Corpus Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Uterine Corpus Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Uterine Corpus Cancer AJCC v8
  • Stage IIIC1 Uterine Corpus Cancer AJCC v8
  • Stage IIIC2 Uterine Corpus Cancer AJCC v8
  • Stage IV Ovarian Cancer AJCC v8
  • Stage IV Uterine Corpus Cancer AJCC v8
  • Stage IVA Ovarian Cancer AJCC v8
  • Stage IVA Uterine Corpus Cancer AJCC v8
  • Stage IVB Ovarian Cancer AJCC v8
  • Stage IVB Uterine Corpus Cancer AJCC v8
Interventions
  • BIOLOGICAL
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page